Cb Lin 0.5mg Tab
Marketer
Serum Institute Of India Pvt Ltd
Composition
Cabergoline (0.5mg)
About Cb Lin 0.5mg Tab
Cb Lin 0.5mg Tab (Cabergoline) is a medication used to treat various conditions like hyperprolactinemia, Parkinson's disease, and acromegaly. It works by stimulating dopamine receptors in the brain. It's important to follow your doctor's instructions carefully regarding dosage and potential side effects. Consult your doctor if you have any concerns or experience any adverse reactions.
Frequently Asked Questions (FAQs)
What is Cb Lin 0.5mg Tab (Cabergoline) used for?
How does Cb Lin 0.5mg Tab (Cabergoline) work?
What are the potential side effects of Cb Lin 0.5mg Tab (Cabergoline)?
Can I drink alcohol while taking Cb Lin 0.5mg Tab (Cabergoline)?
Is Cb Lin 0.5mg Tab (Cabergoline) safe for pregnant women?
Last Updated On 13 Jun. 2025 | 01:41 AM (IST)
Report Error
Was this Product Information helpful?
Some people found this information helpful
User Feedback
Disclaimer
We, at MedCart make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed
medicine-related information to our consumers. However, it should, by no means, be considered a
substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship.
In fact, we detest any form of self-medication without expert advice. The sole purpose of the
information on our portal is to educate our consumers, which helps improve the communication
between a doctor and a patient. The information by no means is complete in its entirety and
should not be used to diagnose or treat any medical condition. No amount of information can
replace the experience and expertise of a doctor, therefore his/her advice always holds
priority and should be followed appropriately.

5k+ people saw this product recently
MRP
₹234.00
10% off applied
In Stock
₹210.60
(₹105.3 per unit)
For 2 Tablet (s)
Inclusive of all Taxes
Delivery Pincode
Check
Delivery in 60-90 mins
Cash on Delivery Available
Easy 7 Days Return Available
Expires on or after Dec 2024
Country of Origin: India
User Feedback